Stockscreener 앱 받기
8.25
1.79%
-0.15
Zynex Inc 주식(ZYXI)의 최신 뉴스
Electrotherapy System Market Future Business Opportunities - openPR
How to Take Advantage of moves in (ZYXI) - Stock Traders Daily
Zynex partners with VA to expand pain management access By Investing.com - Investing.com Canada
Zynex partners with VA to expand pain management access - Investing.com
Zynex's SWOT analysis: pain management firm's stock faces growth hurdles By Investing.com - Investing.com Canada
Zynex's SWOT analysis: pain management firm's stock faces growth hurdles - Investing.com
Zynex partners with VA to offer pain management solutions for veterans - Proactive Investors
Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States (PR Newswire) - Aktiellt
Zynex partners with Veterans Affairs Medical Centers to deliver noninvasive pain relief solutions - Proactive financial news
Zynex, Inc. Sets Second Quarter 2023 Earnings Call - GuruFocus.com
Zynex Announces Completion of Its Laser Pulse Oximetry Trial - The Eastern Progress Online
Zynex CEO outlines plans for 2025 after revenue milestone – ICYMI - Proactive financial news
Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters - The Malaysian Reserve
Zynex to Present at the HC Wainwright Global Investment Conference - The Eastern Progress Online
Zynex UCSF Study Results Demonstrate Laser Technology Benefits i - GuruFocus.com
Zynex study highlights precision of laser-based pulse oximeter in reducing racial bias - Proactive Investors USA
ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial - MSN
Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters – Company AnnouncementFT.com - Financial Times
Zynex Inc. (ZYXI) Tops Q3 Earnings Estimates - MSN
Zynex Sets Third Quarter 2024 Earnings Call - Longview News-Journal
Zynex Inc. Achieves $200M Milestone and Sets Ambitious Goals for 2025 - Proactive Investors UK
Non Invasive Pain Management Devices Market Overall Study - openPR
Objective long/short (ZYXI) Report - Stock Traders Daily
Zynex's (ZYXI) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
CHIEF FINANCIAL OFFICER Moorhead Daniel J was granted 5,000 shares and covered exercise/tax liability with 4,879 shares, decreasing direct ownership by 42% to 35,561 units (SEC Form 4) - Quantisnow
Zynex stock retains buy rating on FDA progress - Investing.com
Zynex stock retains buy rating on FDA progress By Investing.com - Investing.com Canada
Zynex completes clinical verification trial of pulse oximeter - Yahoo Finance
Muscle Stimulator Market Next Big Thing | Major Giants- Axiobionics, Zynex, NeuroMetrix - openPR
Hotchkis & Wiley Capital Management LLC Raises Holdings in Zynex, Inc. (NASDAQ:ZYXI) - MarketBeat
Zynex completes trial for new pulse oximeter technology By Investing.com - Investing.com Canada
Laser-Based Pulse Oximeter Advances Toward FDA Submission - Sleep Review
Zynex eyes FDA submission for NiCO pulse oximeter following successful verification trial - Proactive Investors Australia
Zynex completes trial for new pulse oximeter technology - Investing.com
Zynex Completes Breakthrough Clinical Trial for Next-Gen Laser Pulse Oximeter at Duke University - StockTitan
Zynex Announces Open Oximetry Project Membership - GuruFocus.com
Zynex CFO Daniel Moorhead sells $80,800 in company stock By Investing.com - Investing.com Nigeria
Insider Sell Alert: Daniel Moorhead Sells 10,000 Shares of Zynex Inc (ZYXI) - GuruFocus.com
Zynex CFO Daniel Moorhead sells $80,800 in company stock - Investing.com
Zynex joins Open Oximetry Project as it advances innovative NiCO pulse oximeter - Proactive Investors Australia
0.23%
16.96%
자본화:
|
볼륨(24시간):